Abstract
Tourette syndrome and related tic disorders are complex, neuropsychiatric conditions that likely arise from fronto-subcortical circuit dysfunction. Individuals with these disorders often have additional neuropsychiatric comorbidities such as obsessive compulsive disorder and attention deficit hyperactivity disorder. Given their presumed overlapping genetic and neurodevelopmental origins, it is common for individuals to struggle with symptoms that overlap these diagnostic categories. As a result, careful attention must be paid to complete a thorough evaluation inclusive of these and other neuropsychiatric comorbidities, the presence of which helps to guide appropriate treatment, which includes specific psychotherapeutic and pharmacotherapeutic interventions for each of these disorders. This case of a young man exemplifies the complex and evolving experience of individuals struggling with Tourette syndrome and related disorders. His and his family’s stories provide a lesson in the natural history and diagnostic process of these neuropsychiatric conditions and serve as a starting point for discussion of neuropathological correlates and an in-depth discussion of pharmaco- and psychotherapeutic management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Robertson MM, Eapen V, Singer HS, Martino D, Scharf JM, Paschou P, et al. Gilles de la Tourette syndrome. Nat Rev Dis Prim. 2017;3:16097. Epub 2017/02/06. https://doi.org/10.1038/nrdp.2016.97. PubMed PMID: 28150698.
Jahanshahi M, Obeso I, Rothwell JC, Obeso JA. A fronto-striato-subthalamic-pallidal network for goal-directed and habitual inhibition. Nat Rev Neurosci. 2015;16(12):719–32. Epub 2015/11/05. https://doi.org/10.1038/nrn4038. PubMed PMID: 26530468.
Darrow SM, Hirschtritt ME, Davis LK, Illmann C, Osiecki L, Grados M, et al. Identification of two heritable cross-disorder endophenotypes for Tourette syndrome. Am J Psychiatry. 2017;174(4):387–96. Epub 2016/11/05. https://doi.org/10.1176/appi.ajp.2016.16020240. PubMed PMID: 27809572; PubMed Central PMCID: PMC5378637.
Hirschtritt ME, Lee PC, Pauls DL, Dion Y, Grados MA, Illmann C, et al. Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiat. 2015;72(4):325–33. Epub 2015/02/12. https://doi.org/10.1001/jamapsychiatry.2014.2650. PubMed PMID: 25671412; PubMed Central PMCID: PMCPMC4446055.
Romanelli P, Esposito V, Schaal DW, Heit G. Somatotopy in the basal ganglia: experimental and clinical evidence for segregated sensorimotor channels. Brain Res Brain Res Rev. 2005;48(1):112–28. Epub 2005/02/15. https://doi.org/10.1016/j.brainresrev.2004.09.008. PubMed PMID: 15708631.
Downar J, Blumberger DM, Daskalakis ZJ. The neural crossroads of psychiatric illness: an emerging target for brain stimulation. Trends Cogn Sci. 2016;20(2):107–20. Epub 2015/12/15. https://doi.org/10.1016/j.tics.2015.10.007. PubMed PMID: 26655436.
Whittington C, Pennant M, Kendall T, Glazebrook C, Trayner P, Groom M, et al. Practitioner review: treatments for Tourette syndrome in children and young people – a systematic review. J Child Psychol Psychiatry. 2016;57(9):988–1004. Epub 2016/05/03. https://doi.org/10.1111/jcpp.12556. PubMed PMID: 27132945.
Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303(19):1929–37. Epub 2010/05/21. https://doi.org/10.1001/jama.2010.607. PubMed PMID: 20483969; PubMed Central PMCID: PMC2993317.
Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: the Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA. 2004;292(16):1969–76. Epub 2004/10/28. https://doi.org/10.1001/jama.292.16.1969. PubMed PMID: 15507582.
Bloch MH, Storch EA. Assessment and management of treatment-refractory obsessive-compulsive disorder in children. J Am Acad Child Adolesc Psychiatry. 2015;54(4):251–62. Epub 2015/03/21. https://doi.org/10.1016/j.jaac.2015.01.011. PubMed PMID: 25791142; PubMed Central PMCID: PMC4460245.
Tourette Syndrome Study Group. Treatment of ADHD in children with tics: a randomized controlled trial. Neurology. 2002;58(4):527–36. Epub 2002/02/28 PubMed PMID: 11865128.
Cohen SC, Mulqueen JM, Ferracioli-Oda E, Stuckelman ZD, Coughlin CG, Leckman JF, et al. Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials. J Am Acad Child Adolesc Psychiatry. 2015;54(9):728–36. Epub 2015/08/25. https://doi.org/10.1016/j.jaac.2015.06.011. PubMed PMID: 26299294.
Rodriguez-Oroz MC, Jahanshahi M, Krack P, Litvan I, Macias R, Bezard E, Obeso JA. Initial clinical manifestations of Parkinson’s disease: features and pathophysiological mechanisms. The Lancet. 2009;8:1128–39.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Greenberg, E., Essa, A., Scharf, J.M. (2019). Tricky “Ticcy” Case: Tics/Tourette Syndrome with Co-occurring OCD. In: Hauptman, A., Salpekar, J. (eds) Pediatric Neuropsychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-94998-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-319-94998-7_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-94997-0
Online ISBN: 978-3-319-94998-7
eBook Packages: MedicineMedicine (R0)